Inhibition of breast cancer tissue aromatase activity and estrogen concentrations by the third generation aromatase inhibitor vorozole

被引:0
|
作者
deJong, PC
vandeVen, J
Nortier, JWR
MaitimuSmeele, I
Donker, GH
Thijssen, JHH
Slee, PHTJ
Blankenstein, MA
机构
[1] UNIV UTRECHT HOSP,DEPT INTERNAL MED,UTRECHT,NETHERLANDS
[2] UNIV UTRECHT HOSP,DEPT ENDOCRINOL,UTRECHT,NETHERLANDS
[3] HOSP DIAKONESSENHUIS,DEPT INTERNAL MED,UTRECHT,NETHERLANDS
[4] ST ANTONIUS HOSP,DEPT INTERNAL MED,NIEUWEGEIN,NETHERLANDS
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:19 / 19
页数:1
相关论文
共 50 条
  • [1] Inhibition of breast cancer tissue aromatase activity and estrogen concentrations by the third generation aromatase inhibitor vorozole
    de Jong, PC
    van de Ven, J
    Nortier, JWR
    Maitimu-Smeele, I
    Donker, GH
    Thijssen, JHH
    Slee, PHTJ
    Blankenstein, MA
    [J]. EUROPEAN JOURNAL OF CANCER, 1998, 34 : S5 - S5
  • [2] Inhibition of breast cancer tissue aromatase activity and estrogen concentrations by the third-generation aromatase inhibitor vorozole
    deJong, PC
    vandeVen, J
    NOrtier, HWR
    MaitimuSmeele, I
    Donker, TH
    Thijssen, JHH
    Slee, PHTJ
    Blankenstein, RA
    [J]. CANCER RESEARCH, 1997, 57 (11) : 2109 - 2111
  • [3] Pre-clinical and clinical review of vorozole, a new third generation aromatase inhibitor
    Paul E. Goss
    [J]. Breast Cancer Research and Treatment, 1998, 49 : S59 - S65
  • [4] Pre-clinical and clinical review of vorozole, a new third generation aromatase inhibitor
    Goss, PE
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1998, 49 (Suppl 1) : S59 - S65
  • [5] Aromatase inhibition and breast cancer
    Miller, WR
    [J]. HORMONAL CARCINOGENESIS IV, 2005, : 166 - 180
  • [6] Fulvestrant in advanced breast cancer following following failure of tamoxifen and a third generation aromatase inhibitor
    Wang, J.
    Jain, S.
    Heller, W.
    Mackie, D.
    Watson, V.
    Dweck, M.
    Coombes, R. C.
    Palmieri, C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [7] Aromatase activity and transcripts in breast cancer tissue in relation to the effect of aromatase inhibitors in vitro
    Berstein, LM
    Pauley, RJ
    Yue, W
    Santen, RJ
    [J]. 10TH INTERNATIONAL CONGRESS ON SENOLOGY - BREAST DISEASES OF THE SENOLOGIC INTERNATIONAL SOCIETY, 1998, : 595 - 598
  • [8] Comparison of the systemic and intratumoral effects of tamoxifen and the aromatase inhibitor vorozole in postmenopausal patients with primary breast cancer
    Harper-Wynne, CL
    Sacks, NPM
    Shenton, K
    MacNeill, FA
    Sauven, P
    Laidlaw, IJ
    Rayter, Z
    Miall, S
    Howes, A
    Salter, J
    Hills, MJ
    Lowe, FM
    A'Hern, R
    Nasiri, N
    Doody, D
    Iqbal, J
    Dowsett, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (04) : 1026 - 1035
  • [9] Antitumor activity of Z-endoxifen in aromatase inhibitor-sensitive and aromatase inhibitor-resistant estrogen receptor-positive breast cancer
    Swaathi Jayaraman
    Xiaonan Hou
    Mary J. Kuffel
    Vera J. Suman
    Tanya L. Hoskin
    Kathryn E. Reinicke
    David G. Monroe
    Krishna R. Kalari
    Xiaojia Tang
    Megan A. Zeldenrust
    Jingfei Cheng
    Elizabeth S. Bruinsma
    Sarah A. Buhrow
    Renee M. McGovern
    Stephanie L. Safgren
    Chad A. Walden
    Jodi M. Carter
    Joel M. Reid
    James N. Ingle
    Matthew M. Ames
    John R. Hawse
    Matthew P. Goetz
    [J]. Breast Cancer Research, 22
  • [10] Antitumor activity of Z-endoxifen in aromatase inhibitor-sensitive and aromatase inhibitor-resistant estrogen receptor-positive breast cancer
    Jayaraman, Swaathi
    Hou, Xiaonan
    Kuffel, Mary J.
    Suman, Vera J.
    Hoskin, Tanya L.
    Reinicke, Kathryn E.
    Monroe, David G.
    Kalari, Krishna R.
    Tang, Xiaojia
    Zeldenrust, Megan A.
    Cheng, Jingfei
    Bruinsma, Elizabeth S.
    Buhrow, Sarah A.
    McGovern, Renee M.
    Safgren, Stephanie L.
    Walden, Chad A.
    Carter, Jodi M.
    Reid, Joel M.
    Ingle, James N.
    Ames, Matthew M.
    Hawse, John R.
    Goetz, Matthew P.
    [J]. BREAST CANCER RESEARCH, 2020, 22 (01)